Susquehanna Fundamental Investments, LLC Uni Qure N.V. Transaction History
Susquehanna Fundamental Investments, LLC
- $6.8 Billion
- Q4 2024
A detailed history of Susquehanna Fundamental Investments, LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 38,534 shares of QURE stock, worth $546,412. This represents 0.01% of its overall portfolio holdings.
Number of Shares
38,534Holding current value
$546,412% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding QURE
# of Institutions
169Shares Held
46.5MCall Options Held
1.97MPut Options Held
382K-
Eco R1 Capital, LLC San Francisco, CA3.4MShares$48.2 Million2.81% of portfolio
-
Vestal Point Capital, LP New York, NY3.03MShares$42.9 Million3.17% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.45MShares$34.8 Million2.18% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.18MShares$30.8 Million0.56% of portfolio
-
Franklin Resources Inc San Mateo, CA1.99MShares$28.2 Million0.01% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $663M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...